CLINICAL STUDY OF TA-058
TA-058, new semisynthetic penicillin, was administered to 8 severe infections cases suffering from malignant neoplasms of the hematopoietic organs. Daily doses of TA-058 was 4 to 8 grams, and clinical efficacy was excellent in 1 case, good in 1 case, poor in 5 cases and undecided in 1 case. No serio...
Saved in:
Published in: | CHEMOTHERAPY Vol. 32; no. Supplement2; pp. 356 - 358 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English Japanese |
Published: |
Japanese Society of Chemotherapy
1984
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | TA-058, new semisynthetic penicillin, was administered to 8 severe infections cases suffering from malignant neoplasms of the hematopoietic organs. Daily doses of TA-058 was 4 to 8 grams, and clinical efficacy was excellent in 1 case, good in 1 case, poor in 5 cases and undecided in 1 case. No serious side effects were observed. |
---|---|
ISSN: | 0009-3165 1884-5894 |
DOI: | 10.11250/chemotherapy1953.32.Supplement2_356 |